Literature DB >> 20169424

Acute infection-inflammation and coronary stent thrombosis: an observational study.

Stefano Del Pace1, Maria Boddi, Raffaele Rasoini, Serena Micheli, Camilla Alderighi, Sabina Caciolli, Massimo Margheri, Rosanna Abbate, Gian Franco Gensini.   

Abstract

Coronary stent thrombosis (CST) is a major concern of interventional cardiology. Several risk factors for CST have been identified, but as a whole they do not explain the pathophysiology of CST. This study was designed to investigate whether acute infection-inflammation could facilitate the occurrence of CST. Forty-one patients, aged 66.6 +/- 11 years, consecutively admitted to our catheterization laboratory for acute, subacute or late CST, were retrospectively analysed. Transient acute infection-inflammation on admission for CST was diagnosed by predefined criteria. Prevalence of known risk factors for CST was also investigated. Twenty-one patients (51%) met predefined criteria for the occurrence of acute infection-inflammation. On admission, in these patients, levels of systemic humoral and cellular inflammatory markers were significantly higher than those of patients without recent or ongoing acute infection-inflammation (p < 0.05 for all). 62% of patients with acute infection-inflammation had less than two known risk factors for CST whereas only 37% patients without infection-inflammation showed less than two risk factors (p = 0.03) and showed more frequent interruption of antiplatelet treatment (17 vs. 2.4%, p = 0.02), mean longer stent length (20.5 +/- 4.8 vs. 16.5 +/- 5.1 mm, p = 0.02) and lower left ventricular ejection fraction before CST (42.9 +/- 14 vs. 47.3 +/- 11%, p = 0.02). In conclusion, acute infection-inflammation could play a role in facilitating the occurrence of CST in a subgroup with low risk profile for known risk factors. Our findings, if confirmed, could suggest new opportunities for prevention and treatment of CST.

Entities:  

Mesh:

Year:  2010        PMID: 20169424     DOI: 10.1007/s11739-010-0350-4

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  40 in total

1.  Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials.

Authors:  D E Cutlip; D S Baim; K K Ho; J J Popma; A J Lansky; D J Cohen; J P Carrozza; M S Chauhan; O Rodriguez; R E Kuntz
Journal:  Circulation       Date:  2001-04-17       Impact factor: 29.690

2.  Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up.

Authors:  Duk-Woo Park; Seong-Wook Park; Kyoung-Ha Park; Bong-Ki Lee; Young-Hak Kim; Cheol Whan Lee; Myeong-Ki Hong; Jae-Joong Kim; Seung-Jung Park
Journal:  Am J Cardiol       Date:  2006-06-12       Impact factor: 2.778

3.  Endothelial "stunning" following a brief exposure to endotoxin: a mechanism to link infection and infarction?

Authors:  K Bhagat; R Moss; J Collier; P Vallance
Journal:  Cardiovasc Res       Date:  1996-11       Impact factor: 10.787

4.  Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome.

Authors:  Peter Wenaweser; Christoph Rey; Franz R Eberli; Mario Togni; David Tüller; Stefan Locher; Andrea Remondino; Christian Seiler; Otto M Hess; Bernhard Meier; Stephan Windecker
Journal:  Eur Heart J       Date:  2005-02-23       Impact factor: 29.983

Review 5.  Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?

Authors:  Barry S Coller
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-01-20       Impact factor: 8.311

6.  Stent thrombosis is associated with an impaired response to antiplatelet therapy.

Authors:  Peter Wenaweser; Janine Dörffler-Melly; Katja Imboden; Stephan Windecker; Mario Togni; Bernhard Meier; Andre Haeberli; Otto M Hess
Journal:  J Am Coll Cardiol       Date:  2005-06-07       Impact factor: 24.094

7.  Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

Authors:  Bo Lagerqvist; Stefan K James; Ulf Stenestrand; Johan Lindbäck; Tage Nilsson; Lars Wallentin
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

8.  Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

Authors:  Adnan Kastrati; Julinda Mehilli; Jürgen Pache; Christoph Kaiser; Marco Valgimigli; Henning Kelbaek; Maurizio Menichelli; Manel Sabaté; Maarten J Suttorp; Dietrich Baumgart; Melchior Seyfarth; Matthias E Pfisterer; Albert Schömig
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

9.  Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.

Authors:  Shlomi Matetzky; Boris Shenkman; Victor Guetta; Michael Shechter; Roy Beinart; Roy Bienart; Ilan Goldenberg; Ilya Novikov; Hanna Pres; Naphtali Savion; David Varon; Hanoch Hod
Journal:  Circulation       Date:  2004-06-07       Impact factor: 29.690

Review 10.  Thrombo-embolic complications in bacteraemic infections.

Authors:  V Valtonen; A Kuikka; J Syrjänen
Journal:  Eur Heart J       Date:  1993-12       Impact factor: 29.983

View more
  4 in total

1.  Successful Prasugrel Therapy for Recurrent Left Main Stent Thrombosis in a Clopidogrel Hyporesponder.

Authors:  Yi-Sik Kim; Sang-Rok Lee
Journal:  Tex Heart Inst J       Date:  2015-10-01

2.  Calcium binding-mediated sustained release of minocycline from hydrophilic multilayer coatings targeting infection and inflammation.

Authors:  Zhiling Zhang; Camilla A Nix; Utku K Ercan; Jonathan A Gerstenhaber; Suresh G Joshi; Yinghui Zhong
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

3.  Effect of timing of coronary revascularization in patients with post-infectious myocardial infarction.

Authors:  Chuan-Tsai Tsai; Ya-Wen Lu; Ruey-Hsing Chou; Chin-Sung Kuo; Po-Hsun Huang; Cheng-Hsueh Wu; Shao-Sung Huang
Journal:  PLoS One       Date:  2022-08-18       Impact factor: 3.752

4.  Short-term consequences of angiographically-confirmed coronary stent thrombosis.

Authors:  Christine G Kohn; Jeffrey Kluger; Meena Azeem; Craig I Coleman
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.